FDA permanently fills four senior leadership roles across key agency centers

The short version

• The Trump administration named permanent directors to four key leadership positions across the Food and Drug Administration on Tuesday.[STAT · Associated Press]
• The moves promote acting officials Michael Davis, Karim Mikhail, and Bret Koplow to permanently lead the drug, biologics, and tobacco centers.[STAT · Associated Press]
• Jared Seehafer was appointed to a newly established role as the FDA's first deputy commissioner for technology and artificial intelligence.[STAT]

Key facts

• The Trump administration permanently filled four senior leadership roles at the FDA on Tuesday.[STAT · Associated Press]
• Michael Davis was named permanent director of the Center for Drug Evaluation and Research.[STAT · Associated Press]
• Karim Mikhail was named permanent director of the Center for Biologics Evaluation and Research.[STAT · Associated Press]
• Bret Koplow, an agency attorney since 2011, was named permanent director of the Center for Tobacco Products.[STAT · Associated Press]
• Jared Seehafer was selected to serve as the FDA's first deputy commissioner for technology and artificial intelligence.[STAT]

Sources

Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.

• STAT+: FDA names acting heads of drug and vaccine centers to permanent rolesSTAT metered
• FDA fills four senior roles, including top officials for drugs, vaccines and tobaccoAssociated Press · Wire: associated-press